TVIS42001281
|
Epstein-Barr Virus |
- |
NC_007605.1 |
21762 |
- |
hg19 |
21 |
16054974 |
16054974 |
q21.1 |
MIR99AHG |
Tumor |
Lung carcinoma |
Whole genome and RNA sequencing |
33414372 |
2021 |
ViMIC |
TVIS42001324
|
Epstein-Barr Virus |
- |
NC_007605.1 |
108812 |
- |
hg19 |
21 |
36346164 |
36346164 |
q22.12 |
MORC3 |
Tumor |
Lung carcinoma |
Whole genome and RNA sequencing |
33414372 |
2021 |
ViMIC |
TVIS42001377
|
Epstein-Barr Virus |
- |
NC_007605.1 |
152066 |
- |
hg19 |
21 |
31714867 |
31714867 |
q22.11 |
SCAF4 |
Tumor |
Lung carcinoma |
Whole genome and RNA sequencing |
33414372 |
2021 |
ViMIC |
TVIS42001431
|
Epstein-Barr Virus |
- |
NC_007605.1 |
96470 |
- |
hg19 |
21 |
34781799 |
34781799 |
q22.12 |
LINC01426 |
Tumor |
Lung carcinoma |
Whole genome and RNA sequencing |
33414372 |
2021 |
ViMIC |
TVIS42001492
|
Epstein-Barr Virus |
- |
NC_007605.1 |
71345 |
- |
hg19 |
21 |
22002765 |
22002765 |
q21.1 |
- |
Tumor |
Lung carcinoma |
Whole genome and RNA sequencing |
33414372 |
2021 |
ViMIC |
TVIS30017087
|
Human Immunodeficiency Virus |
- |
- |
- |
- |
hg38 |
21 |
46195808 |
46195809 |
q22.3 |
LSS |
HIV Infected |
HIV infection/AIDS |
Integration site sequencing (IS-seq) method |
33318172 |
2020 |
ViMIC |
TVIS20007709
|
Human Papillomavirus |
HPV18 |
- |
- |
- |
hg19 |
21 |
14995363 |
14995364 |
q11.2 |
NRIP1, ASMER1 |
Tumor |
Cervical cancer |
HPV double capture method |
33191407 |
2021 |
ViMIC |
TVIS20007710
|
Human Papillomavirus |
HPV18 |
- |
- |
- |
hg19 |
21 |
14995351 |
14995352 |
q11.2 |
NRIP1, ASMER1 |
Tumor |
Cervical cancer |
HPV double capture method |
33191407 |
2021 |
ViMIC |
TVIS10025397
|
Hepatitis B virus |
- |
- |
726 |
861 |
hg19 |
21 |
35660277 |
35660278 |
q22.12 |
RUNX1 |
Tumor |
Intrahepatic cholangiocarcinoma |
Hepatitis B virus capture sequencing |
33037855 |
2021 |
ViMIC |
TVIS10025398
|
Hepatitis B virus |
- |
- |
133 |
267 |
hg19 |
21 |
26008724 |
26008725 |
q21.3 |
APP |
Tumor |
Intrahepatic cholangiocarcinoma |
Hepatitis B virus capture sequencing |
33037855 |
2021 |
ViMIC |